Collegium to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in two upcoming investor conferences. The company will engage in fireside chats at the Jefferies London Healthcare Conference on November 19, 2024, at 1:30 p.m. GMT and the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024, at 1:00 p.m. ET. Both sessions will be accessible via webcast through the company's investor relations website, with recordings available for 90 days post-presentation.
Details
News Market Reaction – COLL
The recorded move for COLL in the trading session of this news was -2.39%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com


FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.